Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3024 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR Can Fertility Drugs or IVF Increase My Risk for Cancer? November 15, 2022 Activity and Manageable Toxicity of Pembrolizumab in Some Rare and Ultrarare... July 26, 2023 FDA Grants Accelerated Approval to Futibatinib for Cholangiocarcinoma October 6, 2022 Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or... March 3, 2025 Load more HOT NEWS ctDNA May Guide Who Needs Chemo After Colorectal Cancer Surgery NGS Is Effective in Identifying Actionable Genetic Alterations for Investigational Targeted... EMA Recommends Granting a Marketing Authorisation for Catumaxomab A winding journey into the world of children’s and young people’s...
